Communiqués CanSino Biologics Inc. Shanghai S.E.

Actions

688185

CNE100004BM0

Cours en clôture Shanghai S.E. Autres places de cotation 00:00:00 05/06/2024			Varia. 5j.	Varia. 1 janv.
48,78 ^CNY	-0,14%		-1,13%	-34,54%

31/05	CanSino Biologics Inc. annonce la démission de Nisa Bernice Wing-Yu LEUNG en tant qu'administrateur non exécutif et membre du comité de nomination	CI
21/05	Cansino Biologics investit 160 millions de yuans dans les dépôts structurés de la China Bohai Bank	MT

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

CanSinoBIO CSO Shares the Latest Results of the Company's Globally Innovative Pneumococcal Vaccine	29/04	AQ
CanSinoBIO CSO Shares Latest Results of the Company's Globally Innovative Pneumococcal Vaccine	26/04	AQ
The Commercialization of Asia's First Meningococcal Conjugate Vaccine From CanSinoBIO Represents a Significant Breakthrough	27/03	AQ
CanSino Biologics : CanSinoBIO Initiates Phase Ⅲ Clinical Trial of Group ACYW135 Meningococcal Conjugate Vaccine Menhycia® in Indonesia	25/03	PU
CanSino Biologics : CanSinoBIO and SPIMACO Forge Strategic Partnership to Advance Accessibility of Cutting-Edge Vaccines	18/12	PU
CanSino Biologics : CanSinoBIO Kicks-off the Polio VLP Vaccine Cooperation	04/12	PU
CanSino Biologics : CanSinoBIO's Convidecia Air® Receives Approval in Indonesia	02/03/23	PU
CanSino Biologics : Latest Study Shows Encouraging Results of CanSinoBIO’s mRNA COVID-19 Vaccine as Heterologous Booster	20/02/23	PU
CanSino Biologics : Solution Group Berhad to Start Local Fill and Finish of CanSinoBIO’s COVID-19 Vaccine in Malaysia	13/02/23	PU
CanSino Biologics : CanSinoBIO Announces Encouraging Clinical Progress of its COVID-19 mRNA Vaccine	06/01/23	PU
First Overseas Shipment of CanSinoBIO’s Convidecia Air™ Delivered to Morocco	30/12/22	AQ
CanSino Biologics : First Overseas Shipment of CanSinoBIO’s Convidecia Air™ Delivered to Morocco	28/12/22	PU
CanSino Biologics : CanSinoBIO Leads Sino-Indonesian Collaboration on Mucosal Vaccine Development	17/11/22	PU
CanSino Biologics : CanSinoBIO’s Convidecia Air™ Approved for Emergency Use in Morocco	11/11/22	PU
CanSino Biologics : and AstraZeneca Sign Strategic Collaboration Agreement to Deepen Research on Rare Diseases	10/11/22	PU
CanSino Biologics : Celebrates the Rollout of the Inhaled Vaccine, Convidecia Air™, in Shanghai	26/10/22	PU
CanSino Biologics : CanSinoBIO to Present Latest Data on Convidecia Air™ at the World Vaccine Congress Europe 2022	07/10/22	PU
CanSino Biologics : CanSinoBIO's Convidecia Air™ Receives Approval in China	04/09/22	PU
CanSino Biologics : Convidecia Air™ Receives Clinical Trial Approval in Malaysia	18/08/22	PU
CanSinoBIO's COVID-19 Vaccine Convidecia™ Receives WHO Emergency Use Listing	19/05/22	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

A la une

INTERVIEW - Xuefeng Yu, PDG de CanSino Biologics : Les coulisses de l'accord avec AstraZeneca

Le 31 août 2023 à 12:08